TIGIT and mantle cell lymphoma: When we checked the cell-to-cell communication, we found that expression of CD155/PVR was increased in CD16+ monocytes after relapse and the crosstalk between TIGIT molecules (on MCL cells) with its ligand CD155 (on CD16+ monocytes) was greatly increased after relapse (Fig. 3H).